Your browser doesn't support javascript.
loading
Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe.
Baraliakos, Xenofon; Witte, Torsten; De Clerck, Luc; Frediani, Bruno; Collantes-Estévez, Eduardo; Katsifis, Gkikas; VanLunen, Brenda; Kleine, Elisabeth; Hoepken, Bengt; Bauer, Lars; Goodson, Nicola.
Afiliação
  • Baraliakos X; Rheumazentrum Ruhrgebiet Herne, Ruhr-University, Bochum.
  • Witte T; Hannover Medical School, Hannover Medical School, Hanover, Germany.
  • De Clerck L; Antwerp University Hospital, Antwerp, Belgium.
  • Frediani B; University of Siena, Siena, Italy.
  • Collantes-Estévez E; University of Córdoba and University Hospital Reina Sofia, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain.
  • Katsifis G; Naval Hospital of Athens, Athens, Greece.
  • VanLunen B; UCB Pharma, Raleigh, NC, USA.
  • Kleine E; UCB Pharma, Monheim am Rhein, Germany.
  • Hoepken B; UCB Pharma, Monheim am Rhein, Germany.
  • Bauer L; UCB Pharma, Monheim am Rhein, Germany.
  • Goodson N; Aintree University Hospital NHS Foundation Trust, Liverpool, UK.
Rheumatology (Oxford) ; 60(1): 113-124, 2021 01 05.
Article em En | MEDLINE | ID: mdl-32584415

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antirreumáticos / Espondilartrite / Certolizumab Pegol Tipo de estudo: Clinical_trials / Evaluation_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antirreumáticos / Espondilartrite / Certolizumab Pegol Tipo de estudo: Clinical_trials / Evaluation_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article